Analysis Of Clinical Trial On Alzheimer’s Disease
Melbourne – 19 April 2010: Prana Biotechnology (NASDAQ:PRAN; ASX:PBT) today announced that the authoritative scientific journal, Journal of Alzheimer’s Disease published an article on April 19 about Prana’s lead drug candidate for Alzheimer’s disease, PBT2, providing new analysis that it is effective in reversing dementia symptoms.

Read more on Scoop.co.nz